PCSK9 and coronary artery disorder: In patients with stable coronary artery disease (Fig. 5), higher PCSK9 concentrations were associated with increased cardiovascular events and with female gender, hypertension, statin treatment, C-reactive protein, HbA1c, insulin, total cholesterol and fasting triglycerides, but not with LDL- or HDL-cholesterol.